Goodwin Procter advised Avadel Pharmaceutics on the deal.Avadel announced its royalty agreement with RTW Investments, LP and certain of its affiliates for up to $75 million. Under…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
